Heritable or congenital disorder revision of lists of tests required to be administered for determination of presence.
HF 1029 requires Minnesota's health commissioner to add metachromatic leukodystrophy (MLD) testing to the official list of required medical tests for detecting heritable or congenital disorders. The bill mandates periodic updates to this test list to reflect medical advancements, new testing methods, and factors like test accuracy, treatability of conditions, and disorder severity. This directly affects healthcare providers and patients in Minnesota who rely on these screenings for early detection. The commissioner must follow specific criteria when revising the list, including input from an advisory committee, but revisions are exempt from standard rulemaking procedures.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 17, 2025
Last action Mar 26, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
0
Feb 17, 2025
Introduced
Introduction and first reading, referred to Health Finance and Policy
lower
1 primary · 8 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Paul Torkelson
RRepublican
Co
Amanda Hemmingsen-Jaeger
DDemocratic-Farmer-Labor
Co
Brad Tabke
DDemocratic-Farmer-Labor
Co
Joe Schomacker
RRepublican
Co
Kristin Bahner
DDemocratic-Farmer-Labor
Co
Liz Reyer
DDemocratic-Farmer-Labor
Co
Mary Franson
RRepublican
Co
Robert Bierman
DDemocratic-Farmer-Labor
Co
Zack Stephenson
DDemocratic-Farmer-Labor
Ask Maddy
·
AI policy assistant
Ask Maddy about HF 1029
Scope: MN
Hi! I can help you understand HF 1029. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline